The earnings call reflected a strong start for YUTREPIA, with impressive prescription numbers and conversion rates, positive study results, and a solid financial position. However, challenges with market entry blocks and reliance on channel inventory for initial revenue were noted.

Company Guidance

During the Liquidia Corporation Second Quarter 2025 Financial Results and Corporate Update Conference Call, the company reported a strong start to the commercial launch of YUTREPIA. In just over 11 weeks since approval, more than 900 unique patient prescriptions were reported, with over 550 patient starts. The early success is highlighted by a 75% script-to-start conversion rate within the first 6 weeks. Additionally, the ASCENT study demonstrated promising safety and efficacy data, with only 18.5% of patients discontinuing by week 16 and median improvements in 6-minute walk distance of 31.5 meters. Financially, Liquidia closed the quarter with $173 million in cash and cash equivalents and generated $8.8 million in revenue, including $6.5 million from YUTREPIA sales. The company has signed contracts with major commercial payers and plans to expand its manufacturing capacity to support future growth.

Successful Launch of YUTREPIA

Within 11 weeks of approval, YUTREPIA was launched and has been well received, with over 900 unique patient prescriptions and more than 550 patient starts.

High Conversion Rate

Prescriptions received during the first 6 weeks of launch had a 75% script-to-start conversion rate, indicating strong initial success despite market entry challenges.

Positive ASCENT Study Results

The ASCENT study showed only 18.5% of patients discontinued at week 16, with no serious drug-related adverse events, and a median improvement in 6-minute walk distance of 31.5 meters at week 16.

Strong Financial Position

Liquidia closed the quarter with over $173 million in cash and cash equivalents, with $8.8 million in second-quarter revenue, including $6.5 million from YUTREPIA.

Expansion Plans

Liquidia is expanding its footprint in North Carolina, planning to triple production capacity by 2026 to support YUTREPIA growth.

Liquidia Technologies (LQDA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LQDA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.41 / -	-0.3	―	―	―
Aug 12, 2025	2025 (Q2)	-0.43 / -0.49	-0.37	-32.43% (-0.12)
May 08, 2025	2025 (Q1)	-0.41 / -0.45	-0.54	16.67% (+0.09)	―
Mar 19, 2025	2024 (Q4)	-0.38 / -0.45	-0.43	-4.65% (-0.02)	―
Nov 13, 2024	2024 (Q3)	-0.37 / -0.30	-0.24	-25.00% (-0.06)	―
Aug 07, 2024	2024 (Q2)	-0.34 / -0.37	-0.36	-2.78% (-0.01)	―
May 13, 2024	2024 (Q1)	-0.32 / -0.54	-0.18	-200.00% (-0.36)	―
Mar 13, 2024	2023 (Q4)	-0.24 / -0.43	-0.08	-437.50% (-0.35)	―
Nov 07, 2023	2023 (Q3)	-0.21 / -0.24	-0.14	-71.43% (-0.10)	―
Aug 10, 2023	2023 (Q2)	-0.16 / -0.36	-0.15	-140.00% (-0.21)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LQDA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 12, 2025	$21.20	$24.10	+13.68%
May 08, 2025	$15.53	$15.35	-1.16%
Mar 19, 2025	$14.74	$14.92	+1.22%
Nov 13, 2024	$10.63	$10.27	-3.39%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Liquidia Technologies Inc (LQDA) report earnings?

Liquidia Technologies Inc (LQDA) is schdueled to report earning on Nov 11, 2025, TBA (Confirmed).

What is Liquidia Technologies Inc (LQDA) earnings time?

Liquidia Technologies Inc (LQDA) earnings time is at Nov 11, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LQDA EPS forecast?

LQDA EPS forecast for the fiscal quarter 2025 (Q3) is -0.41.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing